Elevated levels of anti-nuclear IgM in inactive SLE patients (Fig. 3) can initiate C3 cleavage and may result in C3 binding to pathological IgG that is also present in the complex, perhaps at levels that are otherwise not detectable. The gene discussed is C3; the disease is systemic lupus erythematosus.